• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.相关异基因移植供体中的克隆性造血：对筛查和管理的启示
Biol Blood Marrow Transplant. 2020 Jun;26(6):e142-e144. doi: 10.1016/j.bbmt.2020.02.022. Epub 2020 Mar 5.
2
Clonal hematopoiesis of indeterminate potential in older patients having received an allogeneic stem cell transplantation from young donors.接受年轻供者异基因干细胞移植的老年患者中的不确定潜能克隆性造血。
Bone Marrow Transplant. 2020 Mar;55(3):665-668. doi: 10.1038/s41409-019-0575-4. Epub 2019 May 30.
3
Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.供者和相关异基因造血干细胞移植长期存活者中的克隆性造血。
Blood. 2020 Apr 30;135(18):1548-1559. doi: 10.1182/blood.2019003079.
4
Clonal Hematopoiesis of Indeterminate Potential as a Novel Risk Factor for Donor-Derived Leukemia.克隆性造血不定潜能作为供体衍生白血病的一个新的危险因素。
Stem Cell Reports. 2020 Aug 11;15(2):279-291. doi: 10.1016/j.stemcr.2020.07.008.
5
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.供者克隆性造血在异基因造血干细胞移植中的作用。
J Clin Oncol. 2019 Feb 10;37(5):375-385. doi: 10.1200/JCO.2018.79.2184. Epub 2018 Nov 7.
6
Clinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantation.异基因移植治疗的急性髓系白血病患者中克隆性造血的临床影响。
Bone Marrow Transplant. 2019 Aug;54(8):1189-1197. doi: 10.1038/s41409-018-0413-0. Epub 2018 Nov 30.
7
[Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].[克隆性造血：白血病和心血管疾病的危险因素？]
Ned Tijdschr Geneeskd. 2020 Nov 5;164:D5205.
8
Malignant progression of donor-engrafted clonal hematopoiesis in sibling recipients after stem cell transplantation.干细胞移植后同胞受体中供体植入的克隆性造血的恶性进展。
Blood Adv. 2020 Nov 24;4(22):5631-5634. doi: 10.1182/bloodadvances.2020003168.
9
Stem cell donors should not be screened for clonal hematopoiesis.干细胞捐献者不应进行克隆性造血筛查。
Blood Adv. 2020 Feb 25;4(4):789-792. doi: 10.1182/bloodadvances.2019000395.
10
Introduction to a review series on mechanisms and clinical implications of clonal hematopoiesis.克隆性造血的机制及临床意义综述系列介绍
Blood. 2020 Oct 1;136(14):1567. doi: 10.1182/blood.2020007974.

引用本文的文献

1
Surveying local CAR T-cell manufacturing processes to facilitate standardization and expand accessibility.调研当地嵌合抗原受体T细胞制造流程，以促进标准化并扩大可及性。
J Transl Med. 2025 May 6;23(1):507. doi: 10.1186/s12967-025-06400-x.
2
Facilitating the ethical sourcing of donor hematopoietic stem cells for cell and gene therapy research and development.促进用于细胞和基因治疗研发的供者造血干细胞的合乎伦理的来源。
Regen Med. 2024 Jun 2;19(6):317-326. doi: 10.1080/17460751.2024.2357930. Epub 2024 Jun 18.
3
Clonal hematopoiesis in the setting of hematopoietic cell transplantation.造血干细胞移植背景下的克隆性造血。
Semin Hematol. 2024 Feb;61(1):9-15. doi: 10.1053/j.seminhematol.2024.01.011. Epub 2024 Feb 1.
4
Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.供者克隆性造血与移植后受者结局
J Clin Oncol. 2022 Jan 10;40(2):189-201. doi: 10.1200/JCO.21.02286. Epub 2021 Nov 18.

本文引用的文献

1
Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.供者克隆性造血在异基因造血干细胞移植中的作用。
J Clin Oncol. 2019 Feb 10;37(5):375-385. doi: 10.1200/JCO.2018.79.2184. Epub 2018 Nov 7.
2
Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy.识别与干细胞动员不佳和供体来源恶性肿瘤相关的遗传和后天遗传因素。
Biol Blood Marrow Transplant. 2016 Nov;22(11):2100-2103. doi: 10.1016/j.bbmt.2016.08.002. Epub 2016 Aug 4.
3
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
4
Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation.与 BM 捐献相比，PBSC 捐献的严重不良事件风险较低，且癌症风险无增加。
Blood. 2014 Jun 5;123(23):3655-63. doi: 10.1182/blood-2013-12-542464. Epub 2014 Apr 15.
5
Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.健康献血者中的单克隆 B 细胞淋巴增生症：一种出乎意料的常见发现。
Blood. 2014 Feb 27;123(9):1319-26. doi: 10.1182/blood-2013-08-523704. Epub 2013 Dec 17.
6
Can G-CSF cause leukemia in hematopoietic stem cell donors?G-CSF 是否会导致造血干细胞供者患白血病？
Biol Blood Marrow Transplant. 2011 Dec;17(12):1739-46. doi: 10.1016/j.bbmt.2011.07.003. Epub 2011 Jul 13.
7
Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients.慢性淋巴细胞白血病患者同胞移植供体中克隆性B淋巴细胞增多症的鉴定。
Blood. 2009 Sep 24;114(13):2848-9. doi: 10.1182/blood-2009-06-228395.
8
Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Bone Marrow Transplant. 2004 Apr;33(8):855-8. doi: 10.1038/sj.bmt.1704430.

Clonal Hematopoiesis in Related Allogeneic Transplant Donors: Implications for Screening and Management.

作者信息

Seftel Matthew D, Kuxhausen Michelle, Burns Linda, Chitphakdithai Pintip, Confer Dennis, Kiefer Deirdre, Lee Stephanie, Logan Brent, O'Donnell Paul, Pulsipher Michael, Shah Nirali N, Switzer Galen, Shaw Bronwen E

机构信息

Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, Minnesota.

出版信息

Biol Blood Marrow Transplant. 2020 Jun;26(6):e142-e144. doi: 10.1016/j.bbmt.2020.02.022. Epub 2020 Mar 5.

DOI:10.1016/j.bbmt.2020.02.022
PMID:32147534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7440392/
Abstract
摘要